INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

18,684 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$68K
8,310 sh
Apr 13, 2026Apr 14, 2026
Page 281 of 468
← PrevNext →
traded Apr 13, 2026
+1d
SEC Form 4

Evidence

18
CF
Courtemanche Craig F. Jr.Director, Chairman of the Board
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$238K
4,922 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

18
CF
Courtemanche Craig F. Jr.Director, Chairman of the Board
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$135K
2,735 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$11K
2,400 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$17K
3,725 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$18K
3,732 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$40K
8,500 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$17K
3,687 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$17K
3,706 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$16K
3,400 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
1,003 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,399 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
990 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$16K
3,400 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$4,764
1,000 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$4,830
1,014 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$21K
4,442 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

12
HP
Hung PriscillaDirector
VEEVVEEVA SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$115K
750 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$252K
5,927 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$387K
8,973 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.07M
1,860 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

10
MJ
McCallion Kevin J.SVP, Products and Production
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$19K
2,693 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$780K
1,354 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$838K
1,457 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$925K
1,603 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

8
LB
Lewis BryanDirector, CEO/President
IDNIntellicheck, Inc.
Open-market sale · 10b5-1 plan
SELL$80K
10.0K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

7
SB
Sevalia Piyush BSee Remarks
SITMSITIME Corp
Open-market sale · 10b5-1 plan
SELL$530K
1,247 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

7
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$1.15M
9,593 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

7
MJ
Murry Stefan J.Chief Financial Officer
AAOIAPPLIED OPTOELECTRONICS, INC.
Open-market sale · 10b5-1 plan
SELL$546K
4,000 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

6
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$4,437
100 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$144K
1,237 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$73K
614 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$359K
2,959 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$693K
1,210 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

4
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$826K
6,850 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$660K
1,154 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$347K
601 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$160K
281 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$70K
600 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$123K
1,100 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence